On April 28, 2026, Verana Health® unveiled a new AI tool, Agent Claire, aimed at enhancing operational performance for clinicians. This innovative agent is designed to simplify the reporting process for the Merit-based Incentive Payment System (MIPS), which influences Medicare reimbursements, thereby allowing healthcare providers to act more efficiently and reduce risks associated with compliance.
The MIPS program evaluates clinician performance across various dimensions, linking it directly to Medicare payments. The complexity of its reporting demands poses significant challenges for medical practices. Agent Claire seeks to mitigate these difficulties by offering real-time insights and updates on evolving reporting standards, performance thresholds, and quality measures.
Integrated into the Quality Measures Dashboard for members of the American Academy of Ophthalmology’s IRIS® Registry, Agent Claire aims to empower healthcare providers to focus on patient care while effectively managing MIPS requirements. Verana Health's CEO, Sujay Jadhav, emphasized the productivity benefits that AI integration can bring to clinical applications, indicating a shift toward smarter automation in the industry.
Dr. Stephen McLeod, CEO of the American Academy of Ophthalmology, highlighted the initiative’s goal of improving patient care quality while alleviating the compliance burden on physicians.